Protagenic Therapeutics, Inc.
PTIX·74365N202·UQ·equity·Healthcare - Biotechnology-13D/G
PTIX (Protagenic Therapeutics, Inc.) is held by 0 institutional investors as of Q1 2026. Net institutional sentiment: Bearish.
0
Holders
Avg rating
$0
Total Value
0% (6)
Fund Consensus
0 buying - 6 selling
Smart Money Verdict30Negative MomentumConfirmed
Get 5 free verdicts/month - sign up in 10 seconds
See how PTIX's score breaks down across 4 SEC sources
Held by 0 funds
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $22 | 0.0% | -86.66% | 0 | |
Exited | 0(-100.0%) | $64 | 0.0% | -63.24% | 0 | |
Exited | 0(-100.0%) | $15,838 | 0.0% | -63.24% | 0 | |
Exited | 0(-100.0%) | $2 | 0.0% | -86.49% | 0 | |
Exited | 0(-100.0%) | $30,304 | 0.0% | -63.24% | 0 | |
Exited | 0(-100.0%) | $13,001 | 0.0% | -63.24% | 0 |
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
410 holders · $577.8B
UNHUNITEDHEALTH GROUP INC409 holders · $155.8B
JNJJOHNSON & JOHNSON391 holders · $327.3B
DHRDANAHER CORP DEL388 holders · $82.5B
ISRGINTUITIVE SURGICAL INC388 holders · $102.1B
TMOTHERMO FISHER SCIENTIFIC INC387 holders · $127.1B
BSXBOSTON SCIENTIFIC CORP386 holders · $67.5B
MRKMERCK & CO INC381 holders · $175.6B
ABBVABBVIE INC378 holders · $212.3B
ABTABBOTT LABORATORIES376 holders · $108.9B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer